Integrated biomarker profiling of the metabolome associated with impaired fasting glucose and type 2 diabetes mellitus in large-scale Chinese patients

被引：33

作者：

Long, Jianglan ^{[1
,2
,10
]}

Yang, Hui ^{[3
]}

Yang, Zhirui ^{[1
,10
]}

Jia, Qingquan ^{[4
]}

Liu, Liwei ^{[4
]}

Kong, Lingwei ^{[5
]}

Cui, Huijing ^{[5
]}

Ding, Suying ^{[4
]}

Qin, Qian ^{[4
]}

Zhang, Nana ^{[6
]}

Feng, Xingzhong ^{[7
]}

Yan, Shuxun ^{[8
]}

Tang, Jinfa ^{[8
]}

Chen, Shuo ^{[9
]}

Han, Yumei ^{[9
]}

Jiang, Tao ^{[10
]}

Wen, Zhen ^{[10
]}

Qi, Ningning ^{[10
]}

Deng, Kejun ^{[3
]}

Sun, Zhi ^{[4
]}

Lin, Hao ^{[3
]}

Yan, Dan ^{[1
,2
]}

机构：

[1] Capital Med Univ, Beijing Friendship Hosp, 95 Yongan Rd, Beijing 100050, Peoples R China

[2] Beijing Key Lab Evaluat Rational Drug Use, Beijing, Peoples R China

[3] Univ Elect Sci & Technol China, Coll Life Sci & Technol, Chengdu, Sichuan, Peoples R China

[4] Zhengzhou Univ, Affiliated Hosp 1, 1 Jianshe East Rd, Zhengzhou 450052, Henan, Peoples R China

[5] Beijing Jiaotong Univ, Ctr Community Hlth, Beijing, Peoples R China

[6] Kaifeng Hosp Tradit Chinese Med, Dept Pharm, Kaifeng, Henan, Peoples R China

[7] Tsinghua Univ, Dept Endocrinol & Immunol, Yuquan Hosp, Beijing, Peoples R China

[8] Henan Univ CM, Dept Endocrinol, Affiliated Hosp 1, Zhengzhou, Henan, Peoples R China

[9] Beijing Phys Examinat Ctr, Beijing, Peoples R China

[10] Capital Med Univ, Beijing Shijitan Hosp, Beijing, Peoples R China

来源：

CLINICAL AND TRANSLATIONAL MEDICINE | 2021年 / 11卷 / 06期

基金：

中国国家自然科学基金; 国家重点研发计划;

关键词：

RISK;

D O I：

10.1002/ctm2.432

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

引用

页数：7

共 50 条

[1] Integrated biomarker profiling of the metabolome associated with type 2 diabetes mellitus among Tibetan in China
Jinli Meng
Fangfang Huang
Jing Shi
Chenghui Zhang
Li Feng
Suyuan Wang
Hengyan Li
Yongyue Guo
Xin Hu
Xiaomei Li
Wanlin He
Jian Cheng
Yunhong Wu
Diabetology & Metabolic Syndrome, 15
[2] Integrated biomarker profiling of the metabolome associated with type 2 diabetes mellitus among Tibetan in China
Meng, Jinli
Huang, Fangfang
Shi, Jing
Zhang, Chenghui
Feng, Li
Wang, Suyuan
Li, Hengyan
Guo, Yongyue
Hu, Xin
Li, Xiaomei
He, Wanlin
Cheng, Jian
Wu, Yunhong
DIABETOLOGY & METABOLIC SYNDROME, 2023, 15 (01):
[3] Novel strategy to detect Type 2 Diabetes Mellitus in patients with impaired fasting glucose
Perry, RC
Fineberg, N
Baron, AD
DIABETES, 1999, 48 : A89 - A89
[4] Integrated lipids biomarker of the prediabetes and type 2 diabetes mellitus Chinese patients
Yang, Jiaying
Wang, Mei
Yang, Dawei
Yan, Han
Wang, Zhigang
Yan, Dan
Guo, Na
FRONTIERS IN ENDOCRINOLOGY, 2023, 13
[5] Comparison of Transcriptome Between Type 2 Diabetes Mellitus and Impaired Fasting Glucose
Cui, Ying
Chen, Wen
Chi, Jinfeng
Wang, Lei
MEDICAL SCIENCE MONITOR, 2016, 22 : 4699 - 4706
[6] Smoking cessation and the incidence of impaired fasting glucose and type 2 diabetes mellitus
Kawada, Tomoyuki
JOURNAL OF DIABETES AND ITS COMPLICATIONS, 2016, 30 (03) : 561 - 561
[7] Endothelial dysfunction in impaired fasting glycemia, impaired glucose tolerance, and type 2 diabetes mellitus
Su, Ying
Liu, Xiao-Min
Sun, Yan-Ming
Wang, Yue-Ying
Luan, Ying
Wu, Yun
AMERICAN JOURNAL OF CARDIOLOGY, 2008, 102 (04): : 497 - 498
[8] Postprandial lipaemia in patients with impaired fasting glucose, impaired glucose tolerance and diabetes mellitus
Madhu, S. V.
Kant, S.
Srivastava, S.
Kant, R.
Sharma, S. B.
Bhadoria, D. P.
DIABETES RESEARCH AND CLINICAL PRACTICE, 2008, 80 (03) : 380 - 385
[9] The impact of redefining impaired fasting glucose in children at risk for impaired glucose tolerance and type 2 diabetes mellitus
Hadjiyannakis, S
Lawrence, SE
Ward, LM
Lawson, ML
PEDIATRIC RESEARCH, 2004, 55 (04) : 144A - 144A
[10] Circulating Netrin-1 as a Novel Biomarker for Impaired Fasting Glucose and Newly Diagnosed Type 2 Diabetes Mellitus
Jung, Hye-In
Bae, Jaehyun
Han, Eugene
Kim, Gyuri
Lee, Ji-Yeon
Kim, So Ra
Lee, Byung-Wan
Kang, Eun Seok
Ahn, Chul Woo
Cha, Bong-Soo
Lee, Yong-Ho
DIABETES, 2018, 67

← 1 2 3 4 5 →